NCT07145177 2025-12-18177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerUniversity of California, San FranciscoPhase 1 Not yet recruiting30 enrolled
NCT07244393 2025-11-24Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate CancerCellbion Co., Ltd.Phase 1 Not yet recruiting30 enrolled